Entering text into the input field will update the search result below

Rain Therapeutics GAAP EPS of -$0.68 misses by $0.06

Mar. 03, 2022 4:34 PM ETRain Oncology Inc. (RAIN)By: Urvi Shah, SA News Editor
  • Rain Therapeutics press release (NASDAQ:RAIN): Q4 GAAP EPS of -$0.68 misses by $0.06.
  • Q4 Net loss $51.4M.
  • As of December 31, 2021, Rain had $140.2 million in cash, cash equivalents and short-term investments. Rain anticipates that its year-end cash position will provide runway into the

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.